Clinical Trial

Clinical Study of U32 in Patients With Acute Myeloid Leukemia

Name: Clinical Study of U32 in Patients With Acute Myeloid Leukemia — clinical trial record (NCT07036250)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U32 injection in patients with acute myeloid leukemia.

Trial Details

NCT Number	NCT07036250
Lead Sponsor	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Conditions	Acute Myeloid Leukaemia
Enrollment	20 participants
Start Date	2025-07-03
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-25